Global Equilibrium Dialysis Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Equilibrium Dialysis Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Page: 110

Published Date: 02 Apr 2022

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The Equilibrium Dialysis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Equilibrium Dialysis market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Contract Research Organizations accounting for % of the Equilibrium Dialysis global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Linear Regression segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Equilibrium Dialysis include Harvard Apparatus, Thermo Fisher Scientific, Aurora Borealis Control BV, The Nest Group, and Cole-Parmer, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Equilibrium Dialysis market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Linear Regression
Non-Linear Regression

Market segment by Application, can be divided into
Contract Research Organizations
Pharmaceutical and Biotechnology Companies
Others

Market segment by players, this report covers
Harvard Apparatus
Thermo Fisher Scientific
Aurora Borealis Control BV
The Nest Group
Cole-Parmer
Vivaproducts
Merck
3B Pharmaceuticals
ADMEcell
Eurofins Scientific
HT Dialysis
Creative Biolabs
Bioduro
Sekisui XenoTech
SDR Scientific

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Equilibrium Dialysis product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Equilibrium Dialysis, with revenue, gross margin and global market share of Equilibrium Dialysis from 2019 to 2022.
Chapter 3, the Equilibrium Dialysis competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Equilibrium Dialysis market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Equilibrium Dialysis research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Equilibrium Dialysis
1.2 Classification of Equilibrium Dialysis by Type
1.2.1 Overview: Global Equilibrium Dialysis Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Equilibrium Dialysis Revenue Market Share by Type in 2021
1.2.3 Linear Regression
1.2.4 Non-Linear Regression
1.3 Global Equilibrium Dialysis Market by Application
1.3.1 Overview: Global Equilibrium Dialysis Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Contract Research Organizations
1.3.3 Pharmaceutical and Biotechnology Companies
1.3.4 Others
1.4 Global Equilibrium Dialysis Market Size & Forecast
1.5 Global Equilibrium Dialysis Market Size and Forecast by Region
1.5.1 Global Equilibrium Dialysis Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Equilibrium Dialysis Market Size by Region, (2017-2022)
1.5.3 North America Equilibrium Dialysis Market Size and Prospect (2017-2028)
1.5.4 Europe Equilibrium Dialysis Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Equilibrium Dialysis Market Size and Prospect (2017-2028)
1.5.6 South America Equilibrium Dialysis Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Equilibrium Dialysis Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Equilibrium Dialysis Market Drivers
1.6.2 Equilibrium Dialysis Market Restraints
1.6.3 Equilibrium Dialysis Trends Analysis

2 Company Profiles
2.1 Harvard Apparatus
2.1.1 Harvard Apparatus Details
2.1.2 Harvard Apparatus Major Business
2.1.3 Harvard Apparatus Equilibrium Dialysis Product and Solutions
2.1.4 Harvard Apparatus Equilibrium Dialysis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Harvard Apparatus Recent Developments and Future Plans
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business
2.2.3 Thermo Fisher Scientific Equilibrium Dialysis Product and Solutions
2.2.4 Thermo Fisher Scientific Equilibrium Dialysis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.3 Aurora Borealis Control BV
2.3.1 Aurora Borealis Control BV Details
2.3.2 Aurora Borealis Control BV Major Business
2.3.3 Aurora Borealis Control BV Equilibrium Dialysis Product and Solutions
2.3.4 Aurora Borealis Control BV Equilibrium Dialysis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Aurora Borealis Control BV Recent Developments and Future Plans
2.4 The Nest Group
2.4.1 The Nest Group Details
2.4.2 The Nest Group Major Business
2.4.3 The Nest Group Equilibrium Dialysis Product and Solutions
2.4.4 The Nest Group Equilibrium Dialysis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 The Nest Group Recent Developments and Future Plans
2.5 Cole-Parmer
2.5.1 Cole-Parmer Details
2.5.2 Cole-Parmer Major Business
2.5.3 Cole-Parmer Equilibrium Dialysis Product and Solutions
2.5.4 Cole-Parmer Equilibrium Dialysis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Cole-Parmer Recent Developments and Future Plans
2.6 Vivaproducts
2.6.1 Vivaproducts Details
2.6.2 Vivaproducts Major Business
2.6.3 Vivaproducts Equilibrium Dialysis Product and Solutions
2.6.4 Vivaproducts Equilibrium Dialysis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Vivaproducts Recent Developments and Future Plans
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Equilibrium Dialysis Product and Solutions
2.7.4 Merck Equilibrium Dialysis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Merck Recent Developments and Future Plans
2.8 3B Pharmaceuticals
2.8.1 3B Pharmaceuticals Details
2.8.2 3B Pharmaceuticals Major Business
2.8.3 3B Pharmaceuticals Equilibrium Dialysis Product and Solutions
2.8.4 3B Pharmaceuticals Equilibrium Dialysis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 3B Pharmaceuticals Recent Developments and Future Plans
2.9 ADMEcell
2.9.1 ADMEcell Details
2.9.2 ADMEcell Major Business
2.9.3 ADMEcell Equilibrium Dialysis Product and Solutions
2.9.4 ADMEcell Equilibrium Dialysis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 ADMEcell Recent Developments and Future Plans
2.10 Eurofins Scientific
2.10.1 Eurofins Scientific Details
2.10.2 Eurofins Scientific Major Business
2.10.3 Eurofins Scientific Equilibrium Dialysis Product and Solutions
2.10.4 Eurofins Scientific Equilibrium Dialysis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Eurofins Scientific Recent Developments and Future Plans
2.11 HT Dialysis
2.11.1 HT Dialysis Details
2.11.2 HT Dialysis Major Business
2.11.3 HT Dialysis Equilibrium Dialysis Product and Solutions
2.11.4 HT Dialysis Equilibrium Dialysis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 HT Dialysis Recent Developments and Future Plans
2.12 Creative Biolabs
2.12.1 Creative Biolabs Details
2.12.2 Creative Biolabs Major Business
2.12.3 Creative Biolabs Equilibrium Dialysis Product and Solutions
2.12.4 Creative Biolabs Equilibrium Dialysis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Creative Biolabs Recent Developments and Future Plans
2.13 Bioduro
2.13.1 Bioduro Details
2.13.2 Bioduro Major Business
2.13.3 Bioduro Equilibrium Dialysis Product and Solutions
2.13.4 Bioduro Equilibrium Dialysis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Bioduro Recent Developments and Future Plans
2.14 Sekisui XenoTech
2.14.1 Sekisui XenoTech Details
2.14.2 Sekisui XenoTech Major Business
2.14.3 Sekisui XenoTech Equilibrium Dialysis Product and Solutions
2.14.4 Sekisui XenoTech Equilibrium Dialysis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Sekisui XenoTech Recent Developments and Future Plans
2.15 SDR Scientific
2.15.1 SDR Scientific Details
2.15.2 SDR Scientific Major Business
2.15.3 SDR Scientific Equilibrium Dialysis Product and Solutions
2.15.4 SDR Scientific Equilibrium Dialysis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 SDR Scientific Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Equilibrium Dialysis Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Equilibrium Dialysis Players Market Share in 2021
3.2.2 Top 10 Equilibrium Dialysis Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Equilibrium Dialysis Players Head Office, Products and Services Provided
3.4 Equilibrium Dialysis Mergers & Acquisitions
3.5 Equilibrium Dialysis New Entrants and Expansion Plans

4 Market Size Segment by Type
4.1 Global Equilibrium Dialysis Revenue and Market Share by Type (2017-2022)
4.2 Global Equilibrium Dialysis Market Forecast by Type (2023-2028)

5 Market Size Segment by Application
5.1 Global Equilibrium Dialysis Revenue Market Share by Application (2017-2022)
5.2 Global Equilibrium Dialysis Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application
6.1 North America Equilibrium Dialysis Revenue by Type (2017-2028)
6.2 North America Equilibrium Dialysis Revenue by Application (2017-2028)
6.3 North America Equilibrium Dialysis Market Size by Country
6.3.1 North America Equilibrium Dialysis Revenue by Country (2017-2028)
6.3.2 United States Equilibrium Dialysis Market Size and Forecast (2017-2028)
6.3.3 Canada Equilibrium Dialysis Market Size and Forecast (2017-2028)
6.3.4 Mexico Equilibrium Dialysis Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application
7.1 Europe Equilibrium Dialysis Revenue by Type (2017-2028)
7.2 Europe Equilibrium Dialysis Revenue by Application (2017-2028)
7.3 Europe Equilibrium Dialysis Market Size by Country
7.3.1 Europe Equilibrium Dialysis Revenue by Country (2017-2028)
7.3.2 Germany Equilibrium Dialysis Market Size and Forecast (2017-2028)
7.3.3 France Equilibrium Dialysis Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Equilibrium Dialysis Market Size and Forecast (2017-2028)
7.3.5 Russia Equilibrium Dialysis Market Size and Forecast (2017-2028)
7.3.6 Italy Equilibrium Dialysis Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Equilibrium Dialysis Revenue by Type (2017-2028)
8.2 Asia-Pacific Equilibrium Dialysis Revenue by Application (2017-2028)
8.3 Asia-Pacific Equilibrium Dialysis Market Size by Region
8.3.1 Asia-Pacific Equilibrium Dialysis Revenue by Region (2017-2028)
8.3.2 China Equilibrium Dialysis Market Size and Forecast (2017-2028)
8.3.3 Japan Equilibrium Dialysis Market Size and Forecast (2017-2028)
8.3.4 South Korea Equilibrium Dialysis Market Size and Forecast (2017-2028)
8.3.5 India Equilibrium Dialysis Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Equilibrium Dialysis Market Size and Forecast (2017-2028)
8.3.7 Australia Equilibrium Dialysis Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application
9.1 South America Equilibrium Dialysis Revenue by Type (2017-2028)
9.2 South America Equilibrium Dialysis Revenue by Application (2017-2028)
9.3 South America Equilibrium Dialysis Market Size by Country
9.3.1 South America Equilibrium Dialysis Revenue by Country (2017-2028)
9.3.2 Brazil Equilibrium Dialysis Market Size and Forecast (2017-2028)
9.3.3 Argentina Equilibrium Dialysis Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Equilibrium Dialysis Revenue by Type (2017-2028)
10.2 Middle East & Africa Equilibrium Dialysis Revenue by Application (2017-2028)
10.3 Middle East & Africa Equilibrium Dialysis Market Size by Country
10.3.1 Middle East & Africa Equilibrium Dialysis Revenue by Country (2017-2028)
10.3.2 Turkey Equilibrium Dialysis Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Equilibrium Dialysis Market Size and Forecast (2017-2028)
10.3.4 UAE Equilibrium Dialysis Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Equilibrium Dialysis Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Equilibrium Dialysis Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Equilibrium Dialysis Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Equilibrium Dialysis Revenue (USD Million) by Region (2017-2022)
Table 5. Global Equilibrium Dialysis Revenue Market Share by Region (2023-2028)
Table 6. Harvard Apparatus Corporate Information, Head Office, and Major Competitors
Table 7. Harvard Apparatus Major Business
Table 8. Harvard Apparatus Equilibrium Dialysis Product and Solutions
Table 9. Harvard Apparatus Equilibrium Dialysis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 11. Thermo Fisher Scientific Major Business
Table 12. Thermo Fisher Scientific Equilibrium Dialysis Product and Solutions
Table 13. Thermo Fisher Scientific Equilibrium Dialysis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Aurora Borealis Control BV Corporate Information, Head Office, and Major Competitors
Table 15. Aurora Borealis Control BV Major Business
Table 16. Aurora Borealis Control BV Equilibrium Dialysis Product and Solutions
Table 17. Aurora Borealis Control BV Equilibrium Dialysis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. The Nest Group Corporate Information, Head Office, and Major Competitors
Table 19. The Nest Group Major Business
Table 20. The Nest Group Equilibrium Dialysis Product and Solutions
Table 21. The Nest Group Equilibrium Dialysis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Cole-Parmer Corporate Information, Head Office, and Major Competitors
Table 23. Cole-Parmer Major Business
Table 24. Cole-Parmer Equilibrium Dialysis Product and Solutions
Table 25. Cole-Parmer Equilibrium Dialysis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Vivaproducts Corporate Information, Head Office, and Major Competitors
Table 27. Vivaproducts Major Business
Table 28. Vivaproducts Equilibrium Dialysis Product and Solutions
Table 29. Vivaproducts Equilibrium Dialysis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Merck Corporate Information, Head Office, and Major Competitors
Table 31. Merck Major Business
Table 32. Merck Equilibrium Dialysis Product and Solutions
Table 33. Merck Equilibrium Dialysis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. 3B Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 35. 3B Pharmaceuticals Major Business
Table 36. 3B Pharmaceuticals Equilibrium Dialysis Product and Solutions
Table 37. 3B Pharmaceuticals Equilibrium Dialysis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. ADMEcell Corporate Information, Head Office, and Major Competitors
Table 39. ADMEcell Major Business
Table 40. ADMEcell Equilibrium Dialysis Product and Solutions
Table 41. ADMEcell Equilibrium Dialysis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Eurofins Scientific Corporate Information, Head Office, and Major Competitors
Table 43. Eurofins Scientific Major Business
Table 44. Eurofins Scientific Equilibrium Dialysis Product and Solutions
Table 45. Eurofins Scientific Equilibrium Dialysis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. HT Dialysis Corporate Information, Head Office, and Major Competitors
Table 47. HT Dialysis Major Business
Table 48. HT Dialysis Equilibrium Dialysis Product and Solutions
Table 49. HT Dialysis Equilibrium Dialysis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Creative Biolabs Corporate Information, Head Office, and Major Competitors
Table 51. Creative Biolabs Major Business
Table 52. Creative Biolabs Equilibrium Dialysis Product and Solutions
Table 53. Creative Biolabs Equilibrium Dialysis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Bioduro Corporate Information, Head Office, and Major Competitors
Table 55. Bioduro Major Business
Table 56. Bioduro Equilibrium Dialysis Product and Solutions
Table 57. Bioduro Equilibrium Dialysis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Sekisui XenoTech Corporate Information, Head Office, and Major Competitors
Table 59. Sekisui XenoTech Major Business
Table 60. Sekisui XenoTech Equilibrium Dialysis Product and Solutions
Table 61. Sekisui XenoTech Equilibrium Dialysis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. SDR Scientific Corporate Information, Head Office, and Major Competitors
Table 63. SDR Scientific Major Business
Table 64. SDR Scientific Equilibrium Dialysis Product and Solutions
Table 65. SDR Scientific Equilibrium Dialysis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Global Equilibrium Dialysis Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 67. Global Equilibrium Dialysis Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 68. Breakdown of Equilibrium Dialysis by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. Equilibrium Dialysis Players Head Office, Products and Services Provided
Table 70. Equilibrium Dialysis Mergers & Acquisitions in the Past Five Years
Table 71. Equilibrium Dialysis New Entrants and Expansion Plans
Table 72. Global Equilibrium Dialysis Revenue (USD Million) by Type (2017-2022)
Table 73. Global Equilibrium Dialysis Revenue Share by Type (2017-2022)
Table 74. Global Equilibrium Dialysis Revenue Forecast by Type (2023-2028)
Table 75. Global Equilibrium Dialysis Revenue by Application (2017-2022)
Table 76. Global Equilibrium Dialysis Revenue Forecast by Application (2023-2028)
Table 77. North America Equilibrium Dialysis Revenue by Type (2017-2022) & (USD Million)
Table 78. North America Equilibrium Dialysis Revenue by Type (2023-2028) & (USD Million)
Table 79. North America Equilibrium Dialysis Revenue by Application (2017-2022) & (USD Million)
Table 80. North America Equilibrium Dialysis Revenue by Application (2023-2028) & (USD Million)
Table 81. North America Equilibrium Dialysis Revenue by Country (2017-2022) & (USD Million)
Table 82. North America Equilibrium Dialysis Revenue by Country (2023-2028) & (USD Million)
Table 83. Europe Equilibrium Dialysis Revenue by Type (2017-2022) & (USD Million)
Table 84. Europe Equilibrium Dialysis Revenue by Type (2023-2028) & (USD Million)
Table 85. Europe Equilibrium Dialysis Revenue by Application (2017-2022) & (USD Million)
Table 86. Europe Equilibrium Dialysis Revenue by Application (2023-2028) & (USD Million)
Table 87. Europe Equilibrium Dialysis Revenue by Country (2017-2022) & (USD Million)
Table 88. Europe Equilibrium Dialysis Revenue by Country (2023-2028) & (USD Million)
Table 89. Asia-Pacific Equilibrium Dialysis Revenue by Type (2017-2022) & (USD Million)
Table 90. Asia-Pacific Equilibrium Dialysis Revenue by Type (2023-2028) & (USD Million)
Table 91. Asia-Pacific Equilibrium Dialysis Revenue by Application (2017-2022) & (USD Million)
Table 92. Asia-Pacific Equilibrium Dialysis Revenue by Application (2023-2028) & (USD Million)
Table 93. Asia-Pacific Equilibrium Dialysis Revenue by Region (2017-2022) & (USD Million)
Table 94. Asia-Pacific Equilibrium Dialysis Revenue by Region (2023-2028) & (USD Million)
Table 95. South America Equilibrium Dialysis Revenue by Type (2017-2022) & (USD Million)
Table 96. South America Equilibrium Dialysis Revenue by Type (2023-2028) & (USD Million)
Table 97. South America Equilibrium Dialysis Revenue by Application (2017-2022) & (USD Million)
Table 98. South America Equilibrium Dialysis Revenue by Application (2023-2028) & (USD Million)
Table 99. South America Equilibrium Dialysis Revenue by Country (2017-2022) & (USD Million)
Table 100. South America Equilibrium Dialysis Revenue by Country (2023-2028) & (USD Million)
Table 101. Middle East & Africa Equilibrium Dialysis Revenue by Type (2017-2022) & (USD Million)
Table 102. Middle East & Africa Equilibrium Dialysis Revenue by Type (2023-2028) & (USD Million)
Table 103. Middle East & Africa Equilibrium Dialysis Revenue by Application (2017-2022) & (USD Million)
Table 104. Middle East & Africa Equilibrium Dialysis Revenue by Application (2023-2028) & (USD Million)
Table 105. Middle East & Africa Equilibrium Dialysis Revenue by Country (2017-2022) & (USD Million)
Table 106. Middle East & Africa Equilibrium Dialysis Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Equilibrium Dialysis Picture
Figure 2. Global Equilibrium Dialysis Revenue Market Share by Type in 2021
Figure 3. Linear Regression
Figure 4. Non-Linear Regression
Figure 5. Equilibrium Dialysis Revenue Market Share by Application in 2021
Figure 6. Contract Research Organizations Picture
Figure 7. Pharmaceutical and Biotechnology Companies Picture
Figure 8. Others Picture
Figure 9. Global Equilibrium Dialysis Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Equilibrium Dialysis Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Equilibrium Dialysis Revenue Market Share by Region (2017-2028)
Figure 12. Global Equilibrium Dialysis Revenue Market Share by Region in 2021
Figure 13. North America Equilibrium Dialysis Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Equilibrium Dialysis Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Equilibrium Dialysis Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Equilibrium Dialysis Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Equilibrium Dialysis Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Equilibrium Dialysis Market Drivers
Figure 19. Equilibrium Dialysis Market Restraints
Figure 20. Equilibrium Dialysis Market Trends
Figure 21. Harvard Apparatus Recent Developments and Future Plans
Figure 22. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 23. Aurora Borealis Control BV Recent Developments and Future Plans
Figure 24. The Nest Group Recent Developments and Future Plans
Figure 25. Cole-Parmer Recent Developments and Future Plans
Figure 26. Vivaproducts Recent Developments and Future Plans
Figure 27. Merck Recent Developments and Future Plans
Figure 28. 3B Pharmaceuticals Recent Developments and Future Plans
Figure 29. ADMEcell Recent Developments and Future Plans
Figure 30. Eurofins Scientific Recent Developments and Future Plans
Figure 31. HT Dialysis Recent Developments and Future Plans
Figure 32. Creative Biolabs Recent Developments and Future Plans
Figure 33. Bioduro Recent Developments and Future Plans
Figure 34. Sekisui XenoTech Recent Developments and Future Plans
Figure 35. SDR Scientific Recent Developments and Future Plans
Figure 36. Global Equilibrium Dialysis Revenue Share by Players in 2021
Figure 37. Equilibrium Dialysis Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 38. Global Top 3 Players Equilibrium Dialysis Revenue Market Share in 2021
Figure 39. Global Top 10 Players Equilibrium Dialysis Revenue Market Share in 2021
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 41. Global Equilibrium Dialysis Revenue Share by Type in 2021
Figure 42. Global Equilibrium Dialysis Market Share Forecast by Type (2023-2028)
Figure 43. Global Equilibrium Dialysis Revenue Share by Application in 2021
Figure 44. Global Equilibrium Dialysis Market Share Forecast by Application (2023-2028)
Figure 45. North America Equilibrium Dialysis Sales Market Share by Type (2017-2028)
Figure 46. North America Equilibrium Dialysis Sales Market Share by Application (2017-2028)
Figure 47. North America Equilibrium Dialysis Revenue Market Share by Country (2017-2028)
Figure 48. United States Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Canada Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Mexico Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Europe Equilibrium Dialysis Sales Market Share by Type (2017-2028)
Figure 52. Europe Equilibrium Dialysis Sales Market Share by Application (2017-2028)
Figure 53. Europe Equilibrium Dialysis Revenue Market Share by Country (2017-2028)
Figure 54. Germany Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. France Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. United Kingdom Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Russia Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Italy Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Asia-Pacific Equilibrium Dialysis Sales Market Share by Type (2017-2028)
Figure 60. Asia-Pacific Equilibrium Dialysis Sales Market Share by Application (2017-2028)
Figure 61. Asia-Pacific Equilibrium Dialysis Revenue Market Share by Region (2017-2028)
Figure 62. China Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Japan Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South Korea Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. India Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Southeast Asia Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Australia Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South America Equilibrium Dialysis Sales Market Share by Type (2017-2028)
Figure 69. South America Equilibrium Dialysis Sales Market Share by Application (2017-2028)
Figure 70. South America Equilibrium Dialysis Revenue Market Share by Country (2017-2028)
Figure 71. Brazil Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Argentina Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Middle East and Africa Equilibrium Dialysis Sales Market Share by Type (2017-2028)
Figure 74. Middle East and Africa Equilibrium Dialysis Sales Market Share by Application (2017-2028)
Figure 75. Middle East and Africa Equilibrium Dialysis Revenue Market Share by Country (2017-2028)
Figure 76. Turkey Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. UAE Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Harvard Apparatus
Thermo Fisher Scientific
Aurora Borealis Control BV
The Nest Group
Cole-Parmer
Vivaproducts
Merck
3B Pharmaceuticals
ADMEcell
Eurofins Scientific
HT Dialysis
Creative Biolabs
Bioduro
Sekisui XenoTech
SDR Scientific
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Equilibrium Dialysis Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Global Equilibrium Dialysis Market 2022 by Company, Regions, Type and Application, Forecast to 2028

Page: 110

Published Date: 02 Apr 2022

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The Equilibrium Dialysis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Equilibrium Dialysis market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Contract Research Organizations accounting for % of the Equilibrium Dialysis global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Linear Regression segment is altered to a % CAGR between 2022 and 2028.

Global key companies of Equilibrium Dialysis include Harvard Apparatus, Thermo Fisher Scientific, Aurora Borealis Control BV, The Nest Group, and Cole-Parmer, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation
Equilibrium Dialysis market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Linear Regression
Non-Linear Regression

Market segment by Application, can be divided into
Contract Research Organizations
Pharmaceutical and Biotechnology Companies
Others

Market segment by players, this report covers
Harvard Apparatus
Thermo Fisher Scientific
Aurora Borealis Control BV
The Nest Group
Cole-Parmer
Vivaproducts
Merck
3B Pharmaceuticals
ADMEcell
Eurofins Scientific
HT Dialysis
Creative Biolabs
Bioduro
Sekisui XenoTech
SDR Scientific

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Equilibrium Dialysis product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Equilibrium Dialysis, with revenue, gross margin and global market share of Equilibrium Dialysis from 2019 to 2022.
Chapter 3, the Equilibrium Dialysis competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Equilibrium Dialysis market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Equilibrium Dialysis research findings and conclusion, appendix and data source.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Equilibrium Dialysis
1.2 Classification of Equilibrium Dialysis by Type
1.2.1 Overview: Global Equilibrium Dialysis Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Equilibrium Dialysis Revenue Market Share by Type in 2021
1.2.3 Linear Regression
1.2.4 Non-Linear Regression
1.3 Global Equilibrium Dialysis Market by Application
1.3.1 Overview: Global Equilibrium Dialysis Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Contract Research Organizations
1.3.3 Pharmaceutical and Biotechnology Companies
1.3.4 Others
1.4 Global Equilibrium Dialysis Market Size & Forecast
1.5 Global Equilibrium Dialysis Market Size and Forecast by Region
1.5.1 Global Equilibrium Dialysis Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Equilibrium Dialysis Market Size by Region, (2017-2022)
1.5.3 North America Equilibrium Dialysis Market Size and Prospect (2017-2028)
1.5.4 Europe Equilibrium Dialysis Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Equilibrium Dialysis Market Size and Prospect (2017-2028)
1.5.6 South America Equilibrium Dialysis Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Equilibrium Dialysis Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Equilibrium Dialysis Market Drivers
1.6.2 Equilibrium Dialysis Market Restraints
1.6.3 Equilibrium Dialysis Trends Analysis

2 Company Profiles
2.1 Harvard Apparatus
2.1.1 Harvard Apparatus Details
2.1.2 Harvard Apparatus Major Business
2.1.3 Harvard Apparatus Equilibrium Dialysis Product and Solutions
2.1.4 Harvard Apparatus Equilibrium Dialysis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Harvard Apparatus Recent Developments and Future Plans
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business
2.2.3 Thermo Fisher Scientific Equilibrium Dialysis Product and Solutions
2.2.4 Thermo Fisher Scientific Equilibrium Dialysis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.3 Aurora Borealis Control BV
2.3.1 Aurora Borealis Control BV Details
2.3.2 Aurora Borealis Control BV Major Business
2.3.3 Aurora Borealis Control BV Equilibrium Dialysis Product and Solutions
2.3.4 Aurora Borealis Control BV Equilibrium Dialysis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Aurora Borealis Control BV Recent Developments and Future Plans
2.4 The Nest Group
2.4.1 The Nest Group Details
2.4.2 The Nest Group Major Business
2.4.3 The Nest Group Equilibrium Dialysis Product and Solutions
2.4.4 The Nest Group Equilibrium Dialysis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 The Nest Group Recent Developments and Future Plans
2.5 Cole-Parmer
2.5.1 Cole-Parmer Details
2.5.2 Cole-Parmer Major Business
2.5.3 Cole-Parmer Equilibrium Dialysis Product and Solutions
2.5.4 Cole-Parmer Equilibrium Dialysis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Cole-Parmer Recent Developments and Future Plans
2.6 Vivaproducts
2.6.1 Vivaproducts Details
2.6.2 Vivaproducts Major Business
2.6.3 Vivaproducts Equilibrium Dialysis Product and Solutions
2.6.4 Vivaproducts Equilibrium Dialysis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Vivaproducts Recent Developments and Future Plans
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Equilibrium Dialysis Product and Solutions
2.7.4 Merck Equilibrium Dialysis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Merck Recent Developments and Future Plans
2.8 3B Pharmaceuticals
2.8.1 3B Pharmaceuticals Details
2.8.2 3B Pharmaceuticals Major Business
2.8.3 3B Pharmaceuticals Equilibrium Dialysis Product and Solutions
2.8.4 3B Pharmaceuticals Equilibrium Dialysis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 3B Pharmaceuticals Recent Developments and Future Plans
2.9 ADMEcell
2.9.1 ADMEcell Details
2.9.2 ADMEcell Major Business
2.9.3 ADMEcell Equilibrium Dialysis Product and Solutions
2.9.4 ADMEcell Equilibrium Dialysis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 ADMEcell Recent Developments and Future Plans
2.10 Eurofins Scientific
2.10.1 Eurofins Scientific Details
2.10.2 Eurofins Scientific Major Business
2.10.3 Eurofins Scientific Equilibrium Dialysis Product and Solutions
2.10.4 Eurofins Scientific Equilibrium Dialysis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Eurofins Scientific Recent Developments and Future Plans
2.11 HT Dialysis
2.11.1 HT Dialysis Details
2.11.2 HT Dialysis Major Business
2.11.3 HT Dialysis Equilibrium Dialysis Product and Solutions
2.11.4 HT Dialysis Equilibrium Dialysis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 HT Dialysis Recent Developments and Future Plans
2.12 Creative Biolabs
2.12.1 Creative Biolabs Details
2.12.2 Creative Biolabs Major Business
2.12.3 Creative Biolabs Equilibrium Dialysis Product and Solutions
2.12.4 Creative Biolabs Equilibrium Dialysis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Creative Biolabs Recent Developments and Future Plans
2.13 Bioduro
2.13.1 Bioduro Details
2.13.2 Bioduro Major Business
2.13.3 Bioduro Equilibrium Dialysis Product and Solutions
2.13.4 Bioduro Equilibrium Dialysis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Bioduro Recent Developments and Future Plans
2.14 Sekisui XenoTech
2.14.1 Sekisui XenoTech Details
2.14.2 Sekisui XenoTech Major Business
2.14.3 Sekisui XenoTech Equilibrium Dialysis Product and Solutions
2.14.4 Sekisui XenoTech Equilibrium Dialysis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Sekisui XenoTech Recent Developments and Future Plans
2.15 SDR Scientific
2.15.1 SDR Scientific Details
2.15.2 SDR Scientific Major Business
2.15.3 SDR Scientific Equilibrium Dialysis Product and Solutions
2.15.4 SDR Scientific Equilibrium Dialysis Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 SDR Scientific Recent Developments and Future Plans

3 Market Competition, by Players
3.1 Global Equilibrium Dialysis Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Equilibrium Dialysis Players Market Share in 2021
3.2.2 Top 10 Equilibrium Dialysis Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Equilibrium Dialysis Players Head Office, Products and Services Provided
3.4 Equilibrium Dialysis Mergers & Acquisitions
3.5 Equilibrium Dialysis New Entrants and Expansion Plans

4 Market Size Segment by Type
4.1 Global Equilibrium Dialysis Revenue and Market Share by Type (2017-2022)
4.2 Global Equilibrium Dialysis Market Forecast by Type (2023-2028)

5 Market Size Segment by Application
5.1 Global Equilibrium Dialysis Revenue Market Share by Application (2017-2022)
5.2 Global Equilibrium Dialysis Market Forecast by Application (2023-2028)

6 North America by Country, by Type, and by Application
6.1 North America Equilibrium Dialysis Revenue by Type (2017-2028)
6.2 North America Equilibrium Dialysis Revenue by Application (2017-2028)
6.3 North America Equilibrium Dialysis Market Size by Country
6.3.1 North America Equilibrium Dialysis Revenue by Country (2017-2028)
6.3.2 United States Equilibrium Dialysis Market Size and Forecast (2017-2028)
6.3.3 Canada Equilibrium Dialysis Market Size and Forecast (2017-2028)
6.3.4 Mexico Equilibrium Dialysis Market Size and Forecast (2017-2028)

7 Europe by Country, by Type, and by Application
7.1 Europe Equilibrium Dialysis Revenue by Type (2017-2028)
7.2 Europe Equilibrium Dialysis Revenue by Application (2017-2028)
7.3 Europe Equilibrium Dialysis Market Size by Country
7.3.1 Europe Equilibrium Dialysis Revenue by Country (2017-2028)
7.3.2 Germany Equilibrium Dialysis Market Size and Forecast (2017-2028)
7.3.3 France Equilibrium Dialysis Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Equilibrium Dialysis Market Size and Forecast (2017-2028)
7.3.5 Russia Equilibrium Dialysis Market Size and Forecast (2017-2028)
7.3.6 Italy Equilibrium Dialysis Market Size and Forecast (2017-2028)

8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Equilibrium Dialysis Revenue by Type (2017-2028)
8.2 Asia-Pacific Equilibrium Dialysis Revenue by Application (2017-2028)
8.3 Asia-Pacific Equilibrium Dialysis Market Size by Region
8.3.1 Asia-Pacific Equilibrium Dialysis Revenue by Region (2017-2028)
8.3.2 China Equilibrium Dialysis Market Size and Forecast (2017-2028)
8.3.3 Japan Equilibrium Dialysis Market Size and Forecast (2017-2028)
8.3.4 South Korea Equilibrium Dialysis Market Size and Forecast (2017-2028)
8.3.5 India Equilibrium Dialysis Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Equilibrium Dialysis Market Size and Forecast (2017-2028)
8.3.7 Australia Equilibrium Dialysis Market Size and Forecast (2017-2028)

9 South America by Country, by Type, and by Application
9.1 South America Equilibrium Dialysis Revenue by Type (2017-2028)
9.2 South America Equilibrium Dialysis Revenue by Application (2017-2028)
9.3 South America Equilibrium Dialysis Market Size by Country
9.3.1 South America Equilibrium Dialysis Revenue by Country (2017-2028)
9.3.2 Brazil Equilibrium Dialysis Market Size and Forecast (2017-2028)
9.3.3 Argentina Equilibrium Dialysis Market Size and Forecast (2017-2028)

10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Equilibrium Dialysis Revenue by Type (2017-2028)
10.2 Middle East & Africa Equilibrium Dialysis Revenue by Application (2017-2028)
10.3 Middle East & Africa Equilibrium Dialysis Market Size by Country
10.3.1 Middle East & Africa Equilibrium Dialysis Revenue by Country (2017-2028)
10.3.2 Turkey Equilibrium Dialysis Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Equilibrium Dialysis Market Size and Forecast (2017-2028)
10.3.4 UAE Equilibrium Dialysis Market Size and Forecast (2017-2028)

11 Research Findings and Conclusion

12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Equilibrium Dialysis Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Equilibrium Dialysis Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Equilibrium Dialysis Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Equilibrium Dialysis Revenue (USD Million) by Region (2017-2022)
Table 5. Global Equilibrium Dialysis Revenue Market Share by Region (2023-2028)
Table 6. Harvard Apparatus Corporate Information, Head Office, and Major Competitors
Table 7. Harvard Apparatus Major Business
Table 8. Harvard Apparatus Equilibrium Dialysis Product and Solutions
Table 9. Harvard Apparatus Equilibrium Dialysis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 11. Thermo Fisher Scientific Major Business
Table 12. Thermo Fisher Scientific Equilibrium Dialysis Product and Solutions
Table 13. Thermo Fisher Scientific Equilibrium Dialysis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Aurora Borealis Control BV Corporate Information, Head Office, and Major Competitors
Table 15. Aurora Borealis Control BV Major Business
Table 16. Aurora Borealis Control BV Equilibrium Dialysis Product and Solutions
Table 17. Aurora Borealis Control BV Equilibrium Dialysis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. The Nest Group Corporate Information, Head Office, and Major Competitors
Table 19. The Nest Group Major Business
Table 20. The Nest Group Equilibrium Dialysis Product and Solutions
Table 21. The Nest Group Equilibrium Dialysis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Cole-Parmer Corporate Information, Head Office, and Major Competitors
Table 23. Cole-Parmer Major Business
Table 24. Cole-Parmer Equilibrium Dialysis Product and Solutions
Table 25. Cole-Parmer Equilibrium Dialysis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Vivaproducts Corporate Information, Head Office, and Major Competitors
Table 27. Vivaproducts Major Business
Table 28. Vivaproducts Equilibrium Dialysis Product and Solutions
Table 29. Vivaproducts Equilibrium Dialysis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Merck Corporate Information, Head Office, and Major Competitors
Table 31. Merck Major Business
Table 32. Merck Equilibrium Dialysis Product and Solutions
Table 33. Merck Equilibrium Dialysis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. 3B Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 35. 3B Pharmaceuticals Major Business
Table 36. 3B Pharmaceuticals Equilibrium Dialysis Product and Solutions
Table 37. 3B Pharmaceuticals Equilibrium Dialysis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. ADMEcell Corporate Information, Head Office, and Major Competitors
Table 39. ADMEcell Major Business
Table 40. ADMEcell Equilibrium Dialysis Product and Solutions
Table 41. ADMEcell Equilibrium Dialysis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Eurofins Scientific Corporate Information, Head Office, and Major Competitors
Table 43. Eurofins Scientific Major Business
Table 44. Eurofins Scientific Equilibrium Dialysis Product and Solutions
Table 45. Eurofins Scientific Equilibrium Dialysis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. HT Dialysis Corporate Information, Head Office, and Major Competitors
Table 47. HT Dialysis Major Business
Table 48. HT Dialysis Equilibrium Dialysis Product and Solutions
Table 49. HT Dialysis Equilibrium Dialysis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Creative Biolabs Corporate Information, Head Office, and Major Competitors
Table 51. Creative Biolabs Major Business
Table 52. Creative Biolabs Equilibrium Dialysis Product and Solutions
Table 53. Creative Biolabs Equilibrium Dialysis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Bioduro Corporate Information, Head Office, and Major Competitors
Table 55. Bioduro Major Business
Table 56. Bioduro Equilibrium Dialysis Product and Solutions
Table 57. Bioduro Equilibrium Dialysis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Sekisui XenoTech Corporate Information, Head Office, and Major Competitors
Table 59. Sekisui XenoTech Major Business
Table 60. Sekisui XenoTech Equilibrium Dialysis Product and Solutions
Table 61. Sekisui XenoTech Equilibrium Dialysis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. SDR Scientific Corporate Information, Head Office, and Major Competitors
Table 63. SDR Scientific Major Business
Table 64. SDR Scientific Equilibrium Dialysis Product and Solutions
Table 65. SDR Scientific Equilibrium Dialysis Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Global Equilibrium Dialysis Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 67. Global Equilibrium Dialysis Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 68. Breakdown of Equilibrium Dialysis by Company Type (Tier 1, Tier 2 and Tier 3)
Table 69. Equilibrium Dialysis Players Head Office, Products and Services Provided
Table 70. Equilibrium Dialysis Mergers & Acquisitions in the Past Five Years
Table 71. Equilibrium Dialysis New Entrants and Expansion Plans
Table 72. Global Equilibrium Dialysis Revenue (USD Million) by Type (2017-2022)
Table 73. Global Equilibrium Dialysis Revenue Share by Type (2017-2022)
Table 74. Global Equilibrium Dialysis Revenue Forecast by Type (2023-2028)
Table 75. Global Equilibrium Dialysis Revenue by Application (2017-2022)
Table 76. Global Equilibrium Dialysis Revenue Forecast by Application (2023-2028)
Table 77. North America Equilibrium Dialysis Revenue by Type (2017-2022) & (USD Million)
Table 78. North America Equilibrium Dialysis Revenue by Type (2023-2028) & (USD Million)
Table 79. North America Equilibrium Dialysis Revenue by Application (2017-2022) & (USD Million)
Table 80. North America Equilibrium Dialysis Revenue by Application (2023-2028) & (USD Million)
Table 81. North America Equilibrium Dialysis Revenue by Country (2017-2022) & (USD Million)
Table 82. North America Equilibrium Dialysis Revenue by Country (2023-2028) & (USD Million)
Table 83. Europe Equilibrium Dialysis Revenue by Type (2017-2022) & (USD Million)
Table 84. Europe Equilibrium Dialysis Revenue by Type (2023-2028) & (USD Million)
Table 85. Europe Equilibrium Dialysis Revenue by Application (2017-2022) & (USD Million)
Table 86. Europe Equilibrium Dialysis Revenue by Application (2023-2028) & (USD Million)
Table 87. Europe Equilibrium Dialysis Revenue by Country (2017-2022) & (USD Million)
Table 88. Europe Equilibrium Dialysis Revenue by Country (2023-2028) & (USD Million)
Table 89. Asia-Pacific Equilibrium Dialysis Revenue by Type (2017-2022) & (USD Million)
Table 90. Asia-Pacific Equilibrium Dialysis Revenue by Type (2023-2028) & (USD Million)
Table 91. Asia-Pacific Equilibrium Dialysis Revenue by Application (2017-2022) & (USD Million)
Table 92. Asia-Pacific Equilibrium Dialysis Revenue by Application (2023-2028) & (USD Million)
Table 93. Asia-Pacific Equilibrium Dialysis Revenue by Region (2017-2022) & (USD Million)
Table 94. Asia-Pacific Equilibrium Dialysis Revenue by Region (2023-2028) & (USD Million)
Table 95. South America Equilibrium Dialysis Revenue by Type (2017-2022) & (USD Million)
Table 96. South America Equilibrium Dialysis Revenue by Type (2023-2028) & (USD Million)
Table 97. South America Equilibrium Dialysis Revenue by Application (2017-2022) & (USD Million)
Table 98. South America Equilibrium Dialysis Revenue by Application (2023-2028) & (USD Million)
Table 99. South America Equilibrium Dialysis Revenue by Country (2017-2022) & (USD Million)
Table 100. South America Equilibrium Dialysis Revenue by Country (2023-2028) & (USD Million)
Table 101. Middle East & Africa Equilibrium Dialysis Revenue by Type (2017-2022) & (USD Million)
Table 102. Middle East & Africa Equilibrium Dialysis Revenue by Type (2023-2028) & (USD Million)
Table 103. Middle East & Africa Equilibrium Dialysis Revenue by Application (2017-2022) & (USD Million)
Table 104. Middle East & Africa Equilibrium Dialysis Revenue by Application (2023-2028) & (USD Million)
Table 105. Middle East & Africa Equilibrium Dialysis Revenue by Country (2017-2022) & (USD Million)
Table 106. Middle East & Africa Equilibrium Dialysis Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Equilibrium Dialysis Picture
Figure 2. Global Equilibrium Dialysis Revenue Market Share by Type in 2021
Figure 3. Linear Regression
Figure 4. Non-Linear Regression
Figure 5. Equilibrium Dialysis Revenue Market Share by Application in 2021
Figure 6. Contract Research Organizations Picture
Figure 7. Pharmaceutical and Biotechnology Companies Picture
Figure 8. Others Picture
Figure 9. Global Equilibrium Dialysis Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 10. Global Equilibrium Dialysis Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Equilibrium Dialysis Revenue Market Share by Region (2017-2028)
Figure 12. Global Equilibrium Dialysis Revenue Market Share by Region in 2021
Figure 13. North America Equilibrium Dialysis Revenue (USD Million) and Growth Rate (2017-2028)
Figure 14. Europe Equilibrium Dialysis Revenue (USD Million) and Growth Rate (2017-2028)
Figure 15. Asia-Pacific Equilibrium Dialysis Revenue (USD Million) and Growth Rate (2017-2028)
Figure 16. South America Equilibrium Dialysis Revenue (USD Million) and Growth Rate (2017-2028)
Figure 17. Middle East and Africa Equilibrium Dialysis Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Equilibrium Dialysis Market Drivers
Figure 19. Equilibrium Dialysis Market Restraints
Figure 20. Equilibrium Dialysis Market Trends
Figure 21. Harvard Apparatus Recent Developments and Future Plans
Figure 22. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 23. Aurora Borealis Control BV Recent Developments and Future Plans
Figure 24. The Nest Group Recent Developments and Future Plans
Figure 25. Cole-Parmer Recent Developments and Future Plans
Figure 26. Vivaproducts Recent Developments and Future Plans
Figure 27. Merck Recent Developments and Future Plans
Figure 28. 3B Pharmaceuticals Recent Developments and Future Plans
Figure 29. ADMEcell Recent Developments and Future Plans
Figure 30. Eurofins Scientific Recent Developments and Future Plans
Figure 31. HT Dialysis Recent Developments and Future Plans
Figure 32. Creative Biolabs Recent Developments and Future Plans
Figure 33. Bioduro Recent Developments and Future Plans
Figure 34. Sekisui XenoTech Recent Developments and Future Plans
Figure 35. SDR Scientific Recent Developments and Future Plans
Figure 36. Global Equilibrium Dialysis Revenue Share by Players in 2021
Figure 37. Equilibrium Dialysis Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 38. Global Top 3 Players Equilibrium Dialysis Revenue Market Share in 2021
Figure 39. Global Top 10 Players Equilibrium Dialysis Revenue Market Share in 2021
Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 41. Global Equilibrium Dialysis Revenue Share by Type in 2021
Figure 42. Global Equilibrium Dialysis Market Share Forecast by Type (2023-2028)
Figure 43. Global Equilibrium Dialysis Revenue Share by Application in 2021
Figure 44. Global Equilibrium Dialysis Market Share Forecast by Application (2023-2028)
Figure 45. North America Equilibrium Dialysis Sales Market Share by Type (2017-2028)
Figure 46. North America Equilibrium Dialysis Sales Market Share by Application (2017-2028)
Figure 47. North America Equilibrium Dialysis Revenue Market Share by Country (2017-2028)
Figure 48. United States Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Canada Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Mexico Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Europe Equilibrium Dialysis Sales Market Share by Type (2017-2028)
Figure 52. Europe Equilibrium Dialysis Sales Market Share by Application (2017-2028)
Figure 53. Europe Equilibrium Dialysis Revenue Market Share by Country (2017-2028)
Figure 54. Germany Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. France Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. United Kingdom Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Russia Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Italy Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Asia-Pacific Equilibrium Dialysis Sales Market Share by Type (2017-2028)
Figure 60. Asia-Pacific Equilibrium Dialysis Sales Market Share by Application (2017-2028)
Figure 61. Asia-Pacific Equilibrium Dialysis Revenue Market Share by Region (2017-2028)
Figure 62. China Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Japan Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South Korea Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. India Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Southeast Asia Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Australia Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. South America Equilibrium Dialysis Sales Market Share by Type (2017-2028)
Figure 69. South America Equilibrium Dialysis Sales Market Share by Application (2017-2028)
Figure 70. South America Equilibrium Dialysis Revenue Market Share by Country (2017-2028)
Figure 71. Brazil Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Argentina Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Middle East and Africa Equilibrium Dialysis Sales Market Share by Type (2017-2028)
Figure 74. Middle East and Africa Equilibrium Dialysis Sales Market Share by Application (2017-2028)
Figure 75. Middle East and Africa Equilibrium Dialysis Revenue Market Share by Country (2017-2028)
Figure 76. Turkey Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. UAE Equilibrium Dialysis Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Methodology
Figure 80. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Harvard Apparatus
Thermo Fisher Scientific
Aurora Borealis Control BV
The Nest Group
Cole-Parmer
Vivaproducts
Merck
3B Pharmaceuticals
ADMEcell
Eurofins Scientific
HT Dialysis
Creative Biolabs
Bioduro
Sekisui XenoTech
SDR Scientific
jiaGou

Add To Cart

gouMai

Buy Now